Mr. Jeff Ruby reports

NEWTOPIA ANNOUNCES DELAY IN ANNUAL FILINGS

Newtopia Inc. will delay the filing of its audited annual financial statements, management's discussion and analysis, and related chief executive officer and chief financial officer certifications for the financial year ended Dec. 31, 2023, which were due today under Canadian securities law requirements.

The reason for the delay is due to the company's auditor, MNP LLP, requiring additional time to complete its remaining audit and quality procedures. The company notes that there have been no disagreements between the company and the auditor regarding any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedures. The company's management, together with its audit committee, has been working with and will continue to work with its auditor to provide all necessary information and complete the annual filings. MNP has committed to concluding its procedures by no later than May 15, 2024.

As a result of the delay, the company expects to be noted in default by applicable securities regulatory authorities in Canada and that the Ontario Securities Commission, as principal regulator, will issue a failure-to-file cease trade order in accordance with the principles and guidance set out in National Policy 11-207 (Failure-to-File Cease Trade Orders and Revocations in Multiple Jurisdictions) of the Canadian Securities Administrators. The FFCTO is expected to prohibit any trading in securities of the company for so long as it remains in effect in all Canadian jurisdictions in which the company is a reporting issuer, as well as certain other Canadian jurisdictions based on the provisions of local securities legislation, and is anticipated to remain in effect until after the annual filings have been filed. The FFCTO is also expected to result in a suspension of the company's shares from trading on the TSX Venture Exchange, which will continue until the FFCTO is revoked and all TSX-V requirements are satisfied.

The company intends to provide updates if and when necessary in accordance with applicable securities laws.

About Newtopia Inc.

Newtopia is a personalized whole health platform, helping people create positive lifelong habits that prevent, slow or reverse chronic disease while reducing health care costs. The platform leverages genetic, social and behavioural insights to create individualized prevention programs with a focus on metabolic disease, diabetes, mental health challenges, hypertension, weight management and musculoskeletal disorders. With a person-centred approach that combines virtual care, digital tools, connected devices and actionable data science, Newtopia delivers sustainable clinical and financial outcomes. Newtopia serves some of the largest nationwide employers and health plans, and is currently listed in Canada on the TSV Venture Exchange (NEWU) and is quoted in the United States on the OTCQB Venture Market (NEWUF).

We seek Safe Harbor.